Clinical trials recruiting for Breast Carcinoma
74
Recruiting trials
44
US states with sites
16
Countries
20%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 13 |
| Minnesota | 11 |
| Ohio | 9 |
| New York | 8 |
| Michigan | 7 |
| Arizona | 6 |
| Florida | 6 |
| Texas | 6 |
| Massachusetts | 5 |
| Kansas | 4 |
| North Carolina | 4 |
| Illinois | 3 |
Top cities
Rochester, Minnesota 10Duarte, California 7Ann Arbor, Michigan 6Columbus, Ohio 6Houston, Texas 6Boston, Massachusetts 5Jacksonville, Florida 5Buffalo, New York 4Scottsdale, Arizona 4Chicago, Illinois 3
Self-screener
Recruiting trials
- 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
- A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- A New Tool to Promote Patient's Engagement in Their Healthcare Process
- A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
- A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
- A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
- A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
- Access to Genetic Testing in Underserved Patients With Cancer
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
- Cancer Genetic Testing in Ethnic Populations
- Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
- Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
- Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
- Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?
- ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
- EMBRACE: Exercising Together
- Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
- Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
- Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
- FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- From Exclusion to Inclusion: Analysing Follow-up Discontinuity in Breast Cancer
- High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
- Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
- Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
- Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
- Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer
- Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
- Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
- Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- MEASUREMENT OF CIRCULATING MUTATION BURDEN
- MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
- Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
- Metastatic Breast Cancer in Austria
- Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya
- Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
- Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
- Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer
- PARTial BREast RECONstruction With Chest Wall Perforator Flap
- Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
- Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
- Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
- Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
- Preoperative Radiation Therapy and Immediate Breast Reconstruction
- Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
- Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma
- Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
- RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
- Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
- Study of Aerobic Training for People Receiving Treatment for Breast Cancer
- Supporting Health Including Endocrine Treatment for Long Duration
- Surviving Daily Life
- TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
- TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
- Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- The Ohio State University (OSU) SCREEN Community Program
- The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
- Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
- WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
Related conditions
Trials recruiting for Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Lung cancer 2180Prostate cancer 1234Ovarian Carcinoma 10Malignant Solid Neoplasm 30Colorectal Carcinoma 42Lung Carcinoma 30Anatomic Stage III Breast Cancer AJCC v8 39Anatomic Stage II Breast Cancer AJCC v8 35Anatomic Stage I Breast Cancer AJCC v8 30
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.